Literature DB >> 28668489

Pulmonary Clinicopathological Correlation after Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Series.

Lee Gazourian1, Laura Spring2, Emily Meserve3, David Hwang3, Alejandro A Diaz4, Samuel Y Ash4, Vincent T Ho2, Lynette M Sholl3, George R Washko4.   

Abstract

Pulmonary complications are a significant cause of morbidity, mortality, and resource utilization after hematopoietic stem cell transplantation (HSCT). The objective of this study was to compare antemortem clinical suspicion of pulmonary complications and postmortem findings in a modern HSCT cohort. All patients who underwent allogeneic HSCT at our institution (n = 1854) between January 1, 2000 and June 30, 2010 were reviewed and patients who died of any cause greater than 1 year after HSCT and had an unrestricted autopsy available for analysis were included. Presence of pulmonary graft-versus-host disease (GVHD) was assessed by a pathologist blinded to the autopsy report, as previously described by Yousem (1995). A total of 35 (1.9%) patients had autopsies available for review. Airway disease, vascular disease, and interstitial disease were all clinically under-recognized compared with the pathological findings on autopsy. Varying degrees of pathological changes were detected, including 10 (28.6%) patients having bronchiolitis obliterans (BO) and 12 (34.3%) patients having pulmonary veno-occlusive disease (PVOD). Pulmonary manifestations of chronic GVHD, particularly BO and PVOD, were clinically under-recognized in our cohort. Our results suggest that PVOD, which has traditionally been considered a rare complication, may be clinically and histologically under-recognized.
Copyright © 2017 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autopsy; Graft-versus-host disease; Hematopoietic stem cell transplantation

Mesh:

Year:  2017        PMID: 28668489      PMCID: PMC5797990          DOI: 10.1016/j.bbmt.2017.06.009

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  36 in total

Review 1.  Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation.

Authors:  S N Wolff
Journal:  Bone Marrow Transplant       Date:  2002-04       Impact factor: 5.483

2.  Pulmonary veno-occlusive disease following reduced-intensity cord blood transplantation.

Authors:  J A Gutman; C T Allen; D K Madtes; J Schramm; C Delaney
Journal:  Bone Marrow Transplant       Date:  2008-07-21       Impact factor: 5.483

3.  Risk factors for airflow obstruction in recipients of bone marrow transplants.

Authors:  J G Clark; D A Schwartz; N Flournoy; K M Sullivan; S W Crawford; E D Thomas
Journal:  Ann Intern Med       Date:  1987-11       Impact factor: 25.391

4.  Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation.

Authors:  Brandon K C Au; Margaret A Au; Jason W Chien
Journal:  Biol Blood Marrow Transplant       Date:  2010-11-30       Impact factor: 5.742

5.  Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation.

Authors:  Hilde Hylland Uhlving; Claus B Andersen; Ib Jarle Christensen; Magdalena Gormsen; Karen Damgaard Pedersen; Frederik Buchvald; Carsten Heilmann; Kim Gjerum Nielsen; Jann Mortensen; Claus Moser; Henrik Sengeløv; Klaus Gottlob Müller
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-09       Impact factor: 5.742

6.  Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes.

Authors:  Arkadiusz Z Dudek; Hemchandra Mahaseth; Todd E DeFor; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2003-10       Impact factor: 5.742

Review 7.  Management of noninfectious lung injury following hematopoietic cell transplantation.

Authors:  Gregory Yanik; Carrie Kitko
Journal:  Curr Opin Oncol       Date:  2013-03       Impact factor: 3.645

8.  CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.

Authors:  Zoya Kuzmina; Katharina Krenn; Ventzislav Petkov; Ulrike Körmöczi; Roman Weigl; Arno Rottal; Peter Kalhs; Margit Mitterbauer; Lothar Ponhold; Gerhard Dekan; Hildegard T Greinix; Winfried F Pickl
Journal:  Blood       Date:  2013-01-09       Impact factor: 22.113

9.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

Authors:  H M Shulman; K M Sullivan; P L Weiden; G B McDonald; G E Striker; G E Sale; R Hackman; M S Tsoi; R Storb; E D Thomas
Journal:  Am J Med       Date:  1980-08       Impact factor: 4.965

10.  Factors associated with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Authors:  Lee Gazourian; Angela J Rogers; Ruby Ibanga; Gerald L Weinhouse; Victor Pinto-Plata; Jerome Ritz; Robert J Soiffer; Joseph H Antin; George R Washko; Rebecca M Baron; Vincent T Ho
Journal:  Am J Hematol       Date:  2014-02-21       Impact factor: 10.047

View more
  5 in total

1.  Noninfectious complications of hematopoietic cell transplantation.

Authors:  Kirsten M Williams
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  A Systematic Review on Pulmonary Complications Secondary to Hematopoietic Stem Cell Transplantation.

Authors:  Alberto Busmail; Sai Sri Penumetcha; Saher Ahluwalia; Rejja Irfan; Sawleha Arshi Khan; Sai Rohit Reddy; Maria Elisa Vasquez Lopez; Maryam Zahid; Lubna Mohammed
Journal:  Cureus       Date:  2022-05-07

3.  Efficacy and safety of high-dose budesonide/formoterol in patients with bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplant.

Authors:  Kyung Hoon Kim; Jongmin Lee; Hee-Je Kim; Seok Lee; Yoo-Jin Kim; Jong Hyuk Lee; Chin Kook Rhee
Journal:  J Thorac Dis       Date:  2020-08       Impact factor: 2.895

4.  Transbronchial biopsy in the management of pulmonary complications of hematopoietic stem cell transplantation.

Authors:  D N O'Dwyer; A S Duvall; M Xia; T C Hoffman; K S Bloye; C A Bulte; X Zhou; S Murray; B B Moore; G A Yanik
Journal:  Bone Marrow Transplant       Date:  2017-10-23       Impact factor: 5.483

5.  Low- and High-Attenuation Lung Volume in Quantitative Chest CT in Children without Lung Disease.

Authors:  Dimitrios Moutafidis; Maria Gavra; Sotirios Golfinopoulos; Antonios Kattamis; George Chrousos; Christina Kanaka-Gantenbein; Athanasios G Kaditis
Journal:  Children (Basel)       Date:  2021-12-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.